GSN and Parkinson disease: These spanned the two forms of hsa-miR-133, previously linked to PD (hsa-miR-133a, predicted to bind the GTPase GSN and the cancer-linked FRG1B [86], and hsa-miR-133b, also predicted to bind FRG1B.